2014-02-14T09:15:52-06:00 2013-06-30 232932984 PARENTEBEARD LLC 1650 MARKET STREET SUITE 4500 PHILADELPHIA PA 19103 990 2012-07-01 210672684 CORIELL INSTITUTE FOR MEDICAL RESEARCH CORI 8567574824 403 HADDON AVENUE CAMDEN NJ 08103 JOSEPH L MINTZER 8567574824 2014-02-11 1 JULIUS GREEN CPA P00350393 2159720701 2012 2015-11-30 17:44:51Z JOSEPH L MINTZER 403 HADDON AVENUE CAMDEN NJ 08103 20480908 0 X WWW.CORIELL.ORG X 1953 NJ BIOMEDICAL RESEARCH ORGANIZATION DEDICATED TO UNDERSTANDING HUMAN GENETIC DISEASES. 20 18 127 19 0 0 3377510 1231553 17023011 18937358 212154 151957 -24121 158312 20588554 20479180 0 0 0 0 9024321 10152616 0 0 55460 10328843 10381409 19353164 20534025 1235390 -54845 38999719 38815940 12108198 11103046 26891521 27712894 X THE CORIELL INSTITUTE FOR MEDICAL RESEARCH SEEKS TO DISCOVER THE CAUSES OF CANCER AND OTHER GENETIC DISEASES IN ORDER TO IMPROVE THE HEALTH OF HUMANKIND, THROUGH SCIENTIFIC RESEARCH, BANKING OF CELL AND TISSUES, AND EDUCATION. AT THE CORIELL INSTITUTE, OUR MISSION IS TO SUPPORT THE GIFT OF GOOD HEALTH. 0 0 16386880 0 18937358 CORIELL INSTITUTE FOR MEDICAL RESEARCH, FOUNDED IN 1953 AND BASED IN CAMDEN, NEW JERSEY, IS AN INDEPENDENT NON-PROFIT RESEARCH INSTITUTE DEDICATED TO THE STUDY OF THE HUMAN GENOME. EXPERT STAFF AND PIONEERING PROGRAMS IN THE FIELDS OF PERSONALIZED MEDICINE, CELL BIOLOGY, CYTOGENETICS, GENOTYPING, AND BIOBANKING DRIVE OUR MISSION. IT MAINTAINS REPOSITORIES FOR CELL LINES AND DNA AND DISTRIBUTES OVER 20,000 BIOMATERIALS ANNUALLY TO RESEARCHERS NATIONALLY AND INTERNATIONALLY.THE CORIELL PERSONALIZED MEDICINE COLLABORATIVE (CPMC) RESEARCH STUDY IS SEEKING TO UNDERSTAND THE USEFULNESS OF GENETIC RISK AND PHARMACOGENOMICS IN CLINICAL DECISION-MAKING AND HEALTHCARE MANAGEMENT.CORIELL HAS A DISTINGUISHED HISTORY IN CELL BIOLOGY, PURSUING CURRENTLY INDUCED PLURIPOTENT STEM (IPS) CELL RESEARCH. THESE POWERFUL CELLS ARE REVOLUTIONIZING THE WAY HUMAN DISEASE IS STUDIED AND HOW DRUGS ARE DEVELOPED. CORIELL OFFERS CUSTOM RESEARCH SERVICES INCLUDING CELL CULTURE, CYTOGENETIC ANALYSES, AND MOLECULAR BIOLOGY. ITS CLIA-CERTIFIED GENOTYPING AND MICROARRAY CENTER OFFERS HIGH-THROUGHPUT DNA ANALYSIS SYSTEMS USING THE PLATFORMS OF TWO LEADING PROVIDERS.ESSENTIAL TO THE INSTITUTE'S SUPPORT OF INTERNATIONAL SCIENTIFIC RESEARCH IS THE CORIELL BIOBANK. FROM THIS RENOWNED CELL BANK, CORIELL MANAGES AND DISTRIBUTES THE WORLD'S MOST DIVERSE COLLECTION OF CELL LINES, DNA, AND OTHER BIOLOGICAL RESOURCES. THE CORIELL BIOBANK PROVIDED SUPPORT TO THE HUMAN GENOME PROJECT, A WORLDWIDE PROGRAM TO MAP THE ENTIRE HUMAN GENOME, AND TO THE INTERNATIONAL HAPMAP PROJECT, A PROJECT PROVIDING AN EFFICIENT TOOL TO IDENTIFY DISEASE-CAUSING GENES.CORIELL'S BIOBANKING OPERATION IS FUNDED BY SEVERAL NATIONAL INSTITUTES OF HEALTH AWARDS. 16386880 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 1 0 1 0 0 1 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 1 50 0 1 127 1 0 0 0 0 0 0 0 0 0 0 X 20 18 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 NJ PA NY X JOSEPH L MINTZER EXECUTIVE VPCOO 8567574824 403 HADDON AVENUE CAMDEN NJ 08103 MICHAEL F CHRISTMAN PHD 40.00 X X 458833 0 23179 PETER DRISCOLL 1.00 X 0 0 0 JOANNE FREDERICKS 1.00 X 0 0 0 DAVID FRIEDMAN 1.00 X 0 0 0 LIESL HENDERSON 1.00 X 0 0 0 ROBERT KIEP III 1.00 X X 0 0 0 CALVIN KNOWLTON 1.00 X 0 0 0 STEPHEN KOPLIN 1.00 X 0 0 0 CHARLES LORD 1.00 X 0 0 0 CONSTANCE MADARA 1.00 X 0 0 0 MICHAEL L SANYOUR 1.00 X 0 0 0 MARC MASER ESQ 1.00 X 0 0 0 NEWBOLD STRONG 1.00 X 0 0 0 EDWARD VINER 1.00 X 0 0 0 STEVEN J MADORE PHD 40.00 X X 154712 0 24634 JERRY JOHNSON 1.00 X 0 0 0 NICHOLAS KOVICH 1.00 X 0 0 0 WADIA MULLA 1.00 X 0 0 0 FRANK GIORDANO 1.00 X 0 0 0 ARNAUD BASTIEN 1.00 X 0 0 0 JOSEPH L MINTZER 40.00 X 280469 0 34287 JOAN MCMANUS 40.00 X 156162 0 11583 PAULINE JAVORSKI 40.00 X 141251 0 11458 NORMAN P GERRY PHD 40.00 X 131700 0 14681 SCOTT E MEGILL 40.00 X 211279 0 32190 COURTNEY KRONENTHAL 40.00 X 130282 0 20673 MARK BELLAFANTE 40.00 X 128131 0 26069 1792819 0 198754 13 0 1 0 ARCHER & GREINER PC 33 E EUCLID AVENUE HADDONFIELD NJ 08033 LEGAL SVC. 133845 TUNSTALL CONSULTING 13153 N DALE MABRY HWY STE 200 TAMPA FL 33618 CONSULTING 126853 2 16014 1037000 178539 20470 1231553 GOVT FEES & CONTRACTS 621500 12168924 12168924 NON-GOVERNMENT REPOSITORY SERVICE 621500 6716904 6716904 INVESTIGATOR DIRECTED SCIENCE 621500 51530 51530 18937358 145942 145942 1728 1728 0 6015 0 6015 6015 6015 CURRICULUM DESIGN 900099 155000 155000 MISCELLANEOUS INCOME 900099 1846 1846 SPECIAL EVENT REVENUE 900099 1466 1466 158312 20479180 18937358 0 310269 1161962 1161962 6745118 5803446 941672 495797 365507 130290 1218508 978687 239821 531231 418000 113231 133845 133845 74242 74242 43350 43350 1296884 814809 482075 3955659 3933710 21949 2315881 1949224 311197 55460 238277 130395 107882 2025046 1694877 330169 298225 298225 20534025 16386880 4091685 55460 1200 1200 1768884 2097563 3918722 3239523 1009642 1624818 215241 183500 252140 137737 382248 496926 29644318 18397776 12319524 11246542 4911350 6427603 500000 0 13720768 13360528 38999719 38815940 1093021 1279124 0 30000 4688561 3988191 5083909 4908517 1242707 897214 12108198 11103046 X 12249505 12857820 13825438 14038496 816578 816578 26891521 27712894 38999719 38815940 X -54845 707319 4032 164867 X 0 1 X 1 1 1 X 2169754 1696487 3652779 3330518 1231553 12081091 2169754 1696487 3652779 3330518 1231553 12081091 1273231 10807860 439599 176017 100684 218218 147671 1082189 37321 49657 18090 17871 158312 281251 13444531 80030049 0.80390 0.76100 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS INCOME - 2008 AMOUNT: $ 3,771. 2009 AMOUNT: $ 30,407. 2010 AMOUNT: $ 190. 2011 AMOUNT: $ 121. 2012 AMOUNT: $ 3,312. SCIENCE FAIR - 2008 AMOUNT: $ 33,550. 2009 AMOUNT: $ 19,250. 2010 AMOUNT: $ 17,900. 2011 AMOUNT: $ 17,750. MEDICAL SCHOOL CURRICULUM DESIGN - 2012 AMOUNT: $ 155,000. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 43350 43350 20490675 20534025 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 48000 38750 45050 43350 175150 250000 250000 250000 250000 1000000 1500000 5411350 173504 842749 6427603 5601595 10189 -200434 5411350 6915104 239008 998335 2549198 1654 5601595 8686542 878716 2618000 32154 6915104 16274149 93670 -3825261 3856016 8686542 0.27000 0.13000 0.60000 0 0 245000 245000 11618097 5799609 5818488 1995282 1492187 503095 15297109 11105980 4191129 488830 488830 11246542 SUPPLEMENTAL RETIREMENT ACCOUNTS 158109 NEW JERSEY CORD BLOOD BANK 4696150 USE OF RESEARCH FACILITY 6993635 SPLIT-INTEREST AGREEMENTS 905810 OTHER MISCELLANEOUS ASSETS 4185 DEFERRED FINANCING COSTS, NET 94158 UNDER RECOVERY OF IDC 508481 13360528 ADVANCES ON HAND 608830 DERIVATIVE FINANCIAL INSTRUMENT 276242 HOLDING ACCOUNTS 12142 897214 X 22005369 707319 652275 164867 1524461 20480908 -1728 -1728 20479180 21188028 652275 1728 654003 20534025 0 20534025 DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS: PART V, LINE 4: THE INSTITUTE'S ENDOWMENT FUNDS ARE USED TO SUPPORT THE SHORT AND LONG TERM GOALS OF THE INSTITUTE. THE INSTITUTE HAS AN APPROVED SPENDING RATE OF 4.0% FOR BOTH 2013 AND 2012, TO DETERMINE THE AMOUNT OF ENDOWMENT EARNINGS TO BE ALLOCATED TO OPERATIONS, FROM INTERNALLY MANAGED ENDOWMENTS. THE SPENDING RATE, WHICH IS SUBJECT TO REVIEW BY THE INSTITUTE'S BOARD OF TRUSTEES, IS APPLIED TO A MOVING AVERAGE OF ANNUAL ENDOWMENT LEVELS OVER THE PRIOR THREE YEARS. AT ITS DISCRETION THE BOARD MAY APPROVE DRAWS OF ADDITIONAL FUNDS ABOVE THE SPENDING RATE TO SUPPORT SPECIFIC GOALS OF THE INSTITUTE. THE INSTITUTE DID NOT DRAW OR TRANSFER ANY FUNDS DURING THE YEARS ENDING JUNE 30, 2013 OR 2012. DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X, LINE 2: THE INSTITUTE ACCOUNTS FOR UNCERTAINTY IN INCOME TAXES USING A RECOGNITION THRESHOLD OF MORE-LIKELY-THAN NOT TO BE SUSTAINED UPON EXAMINATION BY THE APPROPRIATE TAXING AUTHORITY. MEASUREMENT OF THE TAX UNCERTAINTY OCCURS IF THE RECOGNITION THRESHOLD HAS BEEN MET. MANAGEMENT DETERMINED THAT THERE WERE NO TAX UNCERTAINTIES THAT MET THE RECOGNITION THRESHOLD IN 2013 AND 2012. THE INSTITUTE'S FEDERAL EXEMPT ORGANIZATION BUSINESS INCOME TAX RETURNS FOR YEARS ENDED JUNE 30, 2012, 2011 AND 2010 REMAIN SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE. PART XI, LINE 2D - OTHER ADJUSTMENTS: CHANGE IN VALUE OF SPLIT-INTEREST AGREEMENTS 87,234. CHANGE IN VALUE OF FUTURE BUILDING OCCUPANCY -64,636. CHANGE IN VALUE OF DERIVATIVE FINANCIAL INSTRUMENT 142,269. PART XI, LINE 4B - OTHER ADJUSTMENTS: RENTAL EXPENSES -1,728. PART XII, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSES 1,728. EUROPE 0 0 LICENSING TECHNOLOGY THERE IS NO ACTIVITY IN FOREIGN REGIONS. THE ORGANIZATION RECEIVES ROYALTIES FOR SHARED MEDICAL TECHNOLOGY WITH AN ITALIAN BIO-TECH FIRM. AFRICA 0 0 CONSULTING THE ORGANIZATION HAS A CONSULTING AGREEMENT WITH THE INSTITUTE OF HUMAN VIROLOGY NIGERIA, A CORPORATION ORGANIZED AND EXISTING UNDER THE LAWS OF NIGERIA. DURING THE MOST RECENT FISCAL YEAR, REPORTED EXPENSES WERE RELATED TO EMPLOYEE TRAVEL TO NIGERIA FOR CONSULTING PURPOSES. 2840 0 0 0 0 0 0 2840 0 2840 0 0 0 0 0 0 X X X X X 1 1 0 0 0 0 0 1 0 MICHAEL F CHRISTMAN PHD 423833 0 35000 0 0 0 17500 0 5679 0 482012 0 0 0 STEVEN J MADORE PHD 149712 0 5000 0 0 0 8297 0 16337 0 179346 0 0 0 JOSEPH L MINTZER 260469 0 20000 0 0 0 17500 0 16787 0 314756 0 0 0 JOAN MCMANUS 154162 0 2000 0 0 0 10728 0 855 0 167745 0 0 0 PAULINE JAVORSKI 97695 0 3000 0 40556 0 7166 0 4292 0 152709 0 0 0 SCOTT E MEGILL 201279 0 10000 0 0 0 15607 0 16583 0 243469 0 0 0 COURTNEY KRONENTHAL 120282 0 10000 0 0 0 9446 0 11227 0 150955 0 0 0 MARK BELLAFANTE 128131 0 0 0 0 0 9223 0 16846 0 154200 0 0 0 PART I, LINES 4A-B PAULINE JAVORSKI, THE FORMER DIRECTOR OF HUMAN RESOURCES, WAS TERMINATED IN OCTOBER 2012. SHE RECEIVED $40,555.68 IN SEVERANCE PAY. THE INSTITUTE HAS A SUPPLEMENTAL RETIREMENT PLAN FOR JOSEPH L. MINTZER, EXECUTIVE VICE-PRESIDENT/COO. THE VALUE OF THE PLAN AT 6/30/13 WAS $158,108.90. THE VALUE OF THE ACCOUNT WILL BE PAID IN A SINGLE LUMP SUM TO THE EXECUTIVE OR HIS BENEFICIARY UPON ONE OF THE FOLLOWING (1) 62ND BIRTHDAY, (2) INVOLUNTARY TERMINATION, (3) TOTAL DISABILTIY, OR (4) DEATH. NO CONTRIBUTIONS WERE MADE TO THE PLAN DURING THE CURRENT YEAR. PART I, LINE 7 THE COMPENSATION COMMITTEE DETERMINES BONUSES FOR OFFICERS AND KEY EMPLOYEES BASED UPON VARIOUS PERFORMANCE CRITERIA. A THE CAMDEN COUNTY IMPROVEMENT AUTHORITY 222681222 2008-07-02 6000000 FINANCE THE RENOVATION OF LABORATORY/OFFICE SPACE AND PURCHASE EQUIPMENT 0 0 0 A 2011809 6000000 119000 5881000 2010 0 0 1 1 A 0 0 0 0 0.00000 0.00000 0.00000 0 0 1 A 0 1 0 0 1 1 TD BANK 10.000000000000 0 0 0 0 1 A 1 FORM 990, SCHEDULE K, PART III, LINE 3C REVIEW BY BOND COUNSEL: THE ORGANIZATION IS A RESEARCH FACILITY WHICH DOES NOT HAVE RENTAL AGREEMENTS OR SERVICE CONTRACTS THAT CONSTITUTE A CONTRACT WHICH MIGHT RESULT IN PRIVATE BUSINESS USE. SHOULD THE ORGANIZATION ENTER INTO AN AGREEMENT THAT WOULD NECESSITATE THE REVIEW OF BOND COUNSEL, IT WOULD TAKE ALL NECESSARY STEPS TO ENSURE THAT ALL SAFE HARBOR REQUIREMENTS WERE MET. M CHRISTMAN PHD TRUSTEE/PRESIDENT AND CEO PURCHASE PROPERTY X 250000 183500 0 1 1 183500 FORM 990, PART VI, SECTION A, LINE 1 THE EXECUTIVE COMMITTEE MAY ACT ON BEHALF OF THE BOARD OF TRUSTEES WHEN THE BOARD IS NOT IN SESSION. FORM 990, PART VI, SECTION A, LINE 2 CORIELL TRUSTEES, N. STRONG AND J. FREDERICKS, WORK FOR THE SAME FIRM, PENNSYLVANIA TRUST. CORIELL TRUSTEES, C. KNOWLTON AND M. CHRISTMAN, SERVE AS DIRECTORS ON THE BOARD OF CORIELL LIFE SCIENCES, INC., A FOR-PROFIT COMPANY FORMED BY CORIELL. DURING FY 2013 (6/30/13), CORIELL LIFE SCIENCES, INC. DID NOT RECEIVE ANY INVESTMENT DISTRIBUTIONS AND DID NOT GENERATE ANY REVENUE. FORM 990, PART VI, SECTION B, LINE 11 THE CHAIR OF THE AUDIT COMMITTEE REVIEWS THE FORM 990 AND PRESENTS ITS CONTENTS TO MEMBERS OF THE AUDIT AND EXECUTIVE COMMITTEES. THE FORM IS THEN DISTRIBUTED TO ALL CORIELL TRUSTEES BEFORE FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE CEO ANNUALLY DISTRIBUTES THE CONFLICT OF INTEREST POLICY AND DISCLOSURE STATEMENT TO EACH MEMBER OF THE BOARD OF TRUSTEES. EACH TRUSTEE MUST COMPLETE AND RETURN THE ANNUAL DISCLOSURE STATEMENT TO THE CEO ON A TIMELY BASIS. HE OR SHE MUST INFORM THE CEO AND/OR THE COMMITTEE ON CONFLICTS OF INTEREST DIRECTLY ON A TIMELY BASIS OF ANY POTENTIAL OR ACTUAL CONFLICT OF INTEREST OR OF ANY SITUATION WHICH MIGHT LEAD TO THE APPEARANCE OF A CONFLICT OF INTEREST. IN ADDITION, THE EXECUTIVE VICE PRESIDENT ANNUALLY DISTRIBUTES A COPY OF THE EMPLOYEE CONFLICT OF INTEREST POLICY AND DISCLOSURE STATEMENT TO EACH OFFICER, EXECUTIVE, PROFESSIONAL STAFF MEMBER AND ANY INVESTIGATOR. THESE EMPLOYEES ARE REQUIRED TO SUBMIT THE COMPLETED DISCLOSURE STATEMENT TO THE EXECUTIVE VICE PRESIDENT AND DISCLOSE ANY POTENTIAL OR ACTUAL CONFLICT OF INTEREST. REPORTED CONFLICTS OF INTEREST ARE SHARED WITH THE EXECUTIVE COMMITTEE. ANY BOARD MEMBER WHO HAS A CONFLICT OF INTEREST IS EXCLUDED FROM VOTING ON ANY ISSUE INVOLVING THE CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 USING COMPARABILITY DATA SOURCED FROM AN INDEPENDENT ORGANIZATION, A BOARD OF TRUSTEES APPOINTED COMPENSATION COMMITTEE REVIEWS THE PERFORMANCE AND ESTABLISHES THE ANNUAL COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER AND THE CHIEF OPERATING OFFICER. COMPENSATION DECISIONS ARE DETERMINED TAKING INTO CONSIDERING THE FAIR MARKET RANGE FOR THE INDUSTRY. ALL COMMITTEE DISCUSSIONS ARE DOCUMENTED IN BOARD MINUTES. THE PRESIDENT DETERMINES THE COMPENSATION ANNUALLY FOR ALL OTHER EMPLOYEES, INCLUDING OFFICERS AND KEY EMPLOYEES, BASED ON PERFORMANCE APPRAISALS AND REVIEW. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 9: CHANGE IN VALUE OF SPLIT-INTEREST AGREEMENTS 87,234. CHANGE IN VALUE OF FUTURE BUILDING OCCUPANCY -64,636. CHANGE IN FAIR VALUE OF DERIVATIVE FINANCIAL INSTRUMENT 142,269. RELATED ORGANIZATION: FORM 990, SCHEDULE R, PARTS IV AND V THE ORGANIZATION'S RELATED ENTITY, CORIELLOGIC, HAS BEEN INACTIVE FOR YEARS AND AS SUCH THERE ARE NO ASSETS, INCOME, OR INTERCOMPANY TRANSACTIONS TO REPORT ON SCHEDULE R. CORIELL LIFE SCIENCES 403 HADDON AVENUE CAMDEN NJ 08103 461794812 GENETIC DATA STORAGE AND INTERPRETATION DE CORIELL INSTITUTE FOR MEDICAL RESEARCH C 1.00000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0